当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析 - 现金流量表

皓元医药

(688131)

  

流通市值:159.77亿  总市值:159.77亿
流通股本:2.12亿   总股本:2.12亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,286,991,589.82551,423,146.772,282,090,487.331,610,725,771.04
  收到的税费返还10,550,084.596,393,996.2629,749,559.9419,061,320.64
  收到其他与经营活动有关的现金44,555,940.8523,618,227.6948,177,460.8624,559,495.06
  经营活动现金流入小计1,342,097,615.26581,435,370.722,360,017,508.131,654,346,586.74
  购买商品、接受劳务支付的现金657,540,666.17285,102,550.09847,542,881.66648,812,006.27
  支付给职工以及为职工支付的现金458,347,479.04206,972,753.68771,241,346.76578,383,021.61
  支付的各项税费123,794,738.7959,721,090.17141,755,834.23100,995,020.53
  支付其他与经营活动有关的现金112,845,620.7762,140,653.21217,517,187.17167,148,497.81
  经营活动现金流出小计1,352,528,504.77613,937,047.151,978,057,249.821,495,338,546.22
  经营活动产生的现金流量净额-10,430,889.51-32,501,676.43381,960,258.31159,008,040.52
二、投资活动产生的现金流量:
  收回投资收到的现金1,999,000,0001,069,000,00023,000,00015,000,000
  取得投资收益收到的现金5,431,545.642,787,739.7412,887.67-
  处置固定资产、无形资产和其他长期资产收回的现金净额2,306,477.592,306,477.596,344,531.854,913,172.04
  投资活动现金流入小计2,006,738,023.231,074,094,217.3329,357,419.5219,913,172.04
  购建固定资产、无形资产和其他长期资产支付的现金97,778,461.6188,557,176.63304,462,662.44187,818,409.29
  投资支付的现金1,638,500,000922,500,000499,748,947.22,500,000
  取得子公司及其他营业单位支付的现金--8,800,0008,800,000
  投资活动现金流出小计1,736,278,461.611,011,057,176.63813,011,609.64199,118,409.29
  投资活动产生的现金流量净额270,459,561.6263,037,040.7-783,654,190.12-179,205,237.25
三、筹资活动产生的现金流量:
  吸收投资收到的现金25,553,658-44,017,353.8542,795,377.5
  其中:子公司吸收少数股东投资收到的现金--34,000,00034,000,000
  取得借款收到的现金467,730,500.35291,805,529.861,589,558,358.36562,244,642.29
  筹资活动现金流入小计493,284,158.35291,805,529.861,633,575,712.21605,040,019.79
  偿还债务支付的现金235,907,509.17118,165,086.88737,749,112.43488,345,529.79
  分配股利、利润或偿付利息支付的现金45,771,939.866,348,625.9447,043,968.6144,248,860.5
  支付其他与筹资活动有关的现金24,726,039.1912,358,912.9457,304,104.2235,967,171.55
  筹资活动现金流出小计306,405,488.22136,872,625.76842,097,185.26568,561,561.84
  筹资活动产生的现金流量净额186,878,670.13154,932,904.1791,478,526.9536,478,457.95
四、汇率变动对现金及现金等价物的影响14,329,706.168,134,951.467,845,113.984,215,590.65
五、现金及现金等价物净增加额461,237,048.4193,603,219.83397,629,709.1220,496,851.87
  加:期初现金及现金等价物余额873,095,672.73873,095,672.73475,465,963.61475,465,963.61
  期末现金及现金等价物余额1,334,332,721.131,066,698,892.56873,095,672.73495,962,815.48
补充资料:
  净利润148,696,287.31-197,930,034.58-
  资产减值准备60,966,824.59-131,359,593.72-
  固定资产和投资性房地产折旧52,860,352.82-110,815,258.91-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧52,860,352.82-110,815,258.91-
  无形资产摊销4,686,024.19-9,014,639.61-
  长期待摊费用摊销19,851,714.33-28,271,022.01-
  处置固定资产、无形资产和其他长期资产的损失-616,971.72-567,191.03-
  固定资产报废损失--17,909.22-
  公允价值变动损失-212,602.74--150,068.49-
  财务费用18,087,016.02-36,410,144.92-
  投资损失-1,247,313.04-13,757,656.87-
  递延所得税-22,617,129.06--45,398,098.93-
  其中:递延所得税资产减少-22,617,129.06--30,614,828.23-
    递延所得税负债增加---14,783,270.7-
  存货的减少-215,153,545.07--145,864,424.76-
  经营性应收项目的减少-87,436,239.4--104,595,289.47-
  经营性应付项目的增加-30,183,738.18-65,205,154.69-
  其他20,212,972.46-25,395,817.89-
  现金的期末余额1,334,332,721.13-873,095,672.73-
  减:现金的期初余额873,095,672.73-475,465,963.61-
  现金及现金等价物的净增加额461,237,048.4-397,629,709.12-
公告日期2025-08-292025-04-302025-03-282024-10-30
审计意见(境内)标准无保留意见
TOP↑